Skip to main content
. Author manuscript; available in PMC: 2014 Oct 3.
Published in final edited form as: JAMA. 2013 Oct 2;310(13):1353–1368. doi: 10.1001/jama.2013.278040

Figure 1.

Figure 1

CONSORT Diagram: Women’s Health Initiative trials of postmenopausal hormone therapy through extended follow-up. During the post-intervention and extension phases, fewer than 2% and 4% of women in the estrogen-progestin and estrogen-alone trials, respectively, reported use of hormone therapy.